Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas

被引：10
|
作者：
Tang, Vivian [1 ]
Lu, Rufei [1 ]
Mirchia, Kanish [1 ]
Van Ziffle, Jessica [1 ,2 ]
Devine, Patrick [1 ,2 ]
Lee, Julieann [1 ]
Phillips, Joanna J. J. [1 ,3 ]
Perry, Arie [1 ,3 ]
Raleigh, David R. R. [3 ,4 ]
Lucas, Calixto-Hope G. [1 ,5 ]
Solomon, David A. A. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,Hlth Sci West 451, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Clin Canc Genom Lab, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
[5] Johns Hopkins Univ, Sch Med, Dept Pathol, 1800 Orleans St,Sheikh Zayed Tower Room 2101, Baltimore, MD 21287 USA
来源：
ACTA NEUROPATHOLOGICA | 2023年 / 145卷 / 04期
关键词：
D O I：
10.1007/s00401-023-02544-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：497 / 500
页数：4
相关论文
共 50 条
  • [1] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
    Vivian Tang
    Rufei Lu
    Kanish Mirchia
    Jessica Van Ziffle
    Patrick Devine
    Julieann Lee
    Joanna J. Phillips
    Arie Perry
    David R. Raleigh
    Calixto-Hope G. Lucas
    David A. Solomon
    [J]. Acta Neuropathologica, 2023, 145 : 497 - 500
  • [2] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in higher-grade meningiomas
    Tang, Vivian
    Lucas, Calixto-Hope
    Lu, Rufei
    Mirchia, Kanish
    Sullivan, Daniel
    Van Ziffle, Jessica
    Devine, Patrick
    Lee, Julieann
    Phillips, Joanna
    Perry, Arie
    Raleigh, David
    Solomon, David
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 469 - 470
  • [3] P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
    Vij, Meenakshi
    Cho, Benjamin B. B.
    Yokoda, Raquel T. T.
    Rashidipour, Omid
    Umphlett, Melissa
    Richardson, Timothy E. E.
    Tsankova, Nadejda M. M.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [4] P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
    Meenakshi Vij
    Benjamin B. Cho
    Raquel T. Yokoda
    Omid Rashidipour
    Melissa Umphlett
    Timothy E. Richardson
    Nadejda M. Tsankova
    [J]. Acta Neuropathologica Communications, 11
  • [5] Comparing p16 and MTAP loss of expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma
    Vizcaino, M. A.
    Mendoza, C. Zepeda
    Vaubel, R.
    Nguyen, A. T.
    Trejo-Lopez, J. A.
    Raghunathan, A.
    Jenkins, S.
    Jenkins, R.
    Giannini, C.
    [J]. BRAIN PATHOLOGY, 2023, 33
  • [6] Comparing loss of p16 and MTAP expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma
    Vizcaino, M. Adelita
    Giannini, Caterina
    Vaubel, Rachael A.
    Nguyen, Aivi T.
    Trejo-Lopez, Jorge A.
    Raghunathan, Aditya
    Jenkins, Sarah M.
    Jenkins, Robert B.
    Mendoza, Cinthya J. Zepeda
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024,
  • [7] Investigating the Use of p16 Immunohistochemistry as a Surrogate Marker for CDKN2A/B Homozygous Deletion in Astrocytomas
    Cho, Benjamin
    Umphlett, Melissa
    Tsankova, Nadejda
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 572 - 573
  • [8] Homozygous deletion of CDKN2A (p16/p14) in neuroblastomas.
    Thompson, PM
    Maris, JM
    Hogarty, MD
    Seeger, RC
    Reynolds, CP
    Brodeur, GM
    White, PS
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A327 - A327
  • [9] EVALUATION OF P16 AND MTAP IMMUNOHISTOCHEMICAL EXPRESSION AS SURROGATE MARKERS OF CDKN2A/B DELETION IN MENINGIOMAS
    Ricci, A. A.
    Tampieri, C.
    Nozzoli, F.
    Buccoliero, A. M.
    Mangherini, L.
    di Cantogno, L. Verdun
    Osella-Abate, S.
    Pellerino, A.
    Bruno, F.
    Ruda, R.
    Garbossa, D.
    Massi, D.
    Cassoni, P.
    Bertero, L.
    [J]. NEURO-ONCOLOGY, 2023, 25 : 123 - 123
  • [10] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    Toruner, G.
    Aung, P.
    Esquenazi, Y.
    DeMonte, F.
    Ballester, L.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
12345